Approval · Notice of Compliance 1104 · 2000
ATRIDOX: Notice of Compliance 1104
Issued July 5, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1104
- Date
- July 5, 2000
- Company
- Atrix Laboratories, Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antimicrobial agent for periodontitis
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATRIDOX | 02242473 | Dormant |
Medicinal ingredients
- DOXYCYCLINE HYCLATE 44 MG per UNIT